Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Alaunos Therapeutics (TCRT) Return on Assets (2016 - 2025)

Historic Return on Assets for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to 0.96%.

  • Alaunos Therapeutics' Return on Assets rose 19600.0% to 0.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.96%, marking a year-over-year increase of 19600.0%. This contributed to the annual value of 0.87% for FY2024, which is 1200.0% up from last year.
  • According to the latest figures from Q3 2025, Alaunos Therapeutics' Return on Assets is 0.96%, which was up 19600.0% from 1.18% recorded in Q2 2025.
  • Alaunos Therapeutics' 5-year Return on Assets high stood at 0.45% for Q1 2021, and its period low was 3.83% during Q1 2024.
  • Over the past 5 years, Alaunos Therapeutics' median Return on Assets value was 0.96% (recorded in 2025), while the average stood at 1.39%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -31400bps in 2024, then surged by 24700bps in 2025.
  • Over the past 5 years, Alaunos Therapeutics' Return on Assets (Quarter) stood at 0.55% in 2021, then fell by -6bps to 0.58% in 2022, then tumbled by -352bps to 2.62% in 2023, then skyrocketed by 42bps to 1.53% in 2024, then surged by 37bps to 0.96% in 2025.
  • Its Return on Assets was 0.96% in Q3 2025, compared to 1.18% in Q2 2025 and 1.71% in Q1 2025.